{"id":5191,"date":"2020-12-22T10:38:51","date_gmt":"2020-12-22T09:38:51","guid":{"rendered":"https:\/\/staybletherapeutics.com\/sv\/?p=5191"},"modified":"2020-12-22T10:38:51","modified_gmt":"2020-12-22T09:38:51","slug":"inside-stayble-december-2020","status":"publish","type":"post","link":"https:\/\/staybletherapeutics.com\/sv\/presentationer\/inside-stayble-december-2020\/","title":{"rendered":"Inside Stayble: December 2020"},"content":{"rendered":"<p style=\"font-weight: 400;\">I december 2020 uppdateringen ger VD Andreas Gerward mer information kring bolagets kommande f\u00f6retr\u00e4desemission samt reflekterar \u00f6ver 2020 och 2021.<\/p>\n<p style=\"font-weight: 400;\">Inside Stayble \u00e4r en ny kommunikationskanal f\u00f6r att ge aktie\u00e4gare m\u00e5nadsvisa uppdateringar om Stayble Therapeutics och det kliniska utvecklingsprogrammet f\u00f6r STA363 i kronisk l\u00e4ndryggssm\u00e4rta.<\/p>\n<p style=\"font-weight: 400;\">Stayble \u00e4r listat p\u00e5 Nasdaq First North (STABL).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>I december 2020 uppdateringen ger VD Andreas Gerward mer information kring bolagets kommande f\u00f6retr\u00e4desemission samt reflekterar \u00f6ver 2020 och 2021. Inside Stayble \u00e4r en ny kommunikationskanal f\u00f6r att ge aktie\u00e4gare&#8230;<\/p>\n","protected":false},"author":1,"featured_media":5178,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/posts\/5191"}],"collection":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/comments?post=5191"}],"version-history":[{"count":1,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/posts\/5191\/revisions"}],"predecessor-version":[{"id":5192,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/posts\/5191\/revisions\/5192"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/media\/5178"}],"wp:attachment":[{"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/media?parent=5191"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/categories?post=5191"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staybletherapeutics.com\/sv\/wp-json\/wp\/v2\/tags?post=5191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}